A novel magnetic targeting anti-tumour drug delivery system (Fe3O4/KCTS-CHE) was designed using magnetic Fe3O4/chitosan alpha-ketoglutaric acid (Fe3O4/KCTS) as carrier and chelerythrine (CHE) as an anti-tumour drug model. Moreover, the anti-tumour activities and mechanisms of Fe3O4/KCTS-CHE were investigated.